Temporin-La

General Information


DRACP ID  DRACP00404

Peptide Name   Temporin-La

Sequence  LLRHVVKILEKYL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Temporins family

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SW1116 Colon adenocarcinoma Carcinoma 57.62 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
SMMC-7721 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 52.77 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 52.32 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
Hep-G2 Hepatoblastoma; Hepatoblastoma Blastoma 50.90 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
BGC-823 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 48.19 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
A549 Lung adenocarcinoma Carcinoma 45.62 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
HL-7702(L-02) Human papillomavirus-related endocervical adenocarcinoma Carcinoma 37.22 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
MEC Cholangiocarcinoma; Cholangiocarcinoma Carcinoma 24.15Inhibition ratio at 50 µg/ml MTT assay 24 h 1

Hemolytic Activity  Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml

Normal (non-cancerous) Cytotoxicity  Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml

Target  Not available

Affinity  Not available

Mechanism  A membrane-disturbing action seems to be the major mechanism for cell death

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00404

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C78H134N20O17

Absent amino acids  ACDFGMNPQSTW

Common amino acids  L

Mass  183828

Pl  10.24

Basic residues  4

Acidic residues  1

Hydrophobic residues  7

Net charge  3

Boman Index  -495

Hydrophobicity  60

Aliphatic Index  194.62

Half Life 
  Mammalian: >20 hour
  Yeast: >20 hour
  E.coli: ?

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22641352

Title  Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain

Doi 10.1002/psc.2420

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.